Inmunidad de las Mucosas y Alergia: de la Inmunopatología a la Terapia.
Hospital San Pedro de Alcántara
Cáceres, EspañaPublicaciones en colaboración con investigadores/as de Hospital San Pedro de Alcántara (8)
2022
-
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)
Clinical Gastroenterology and Hepatology, Vol. 20, Núm. 10, pp. 2243-2257
-
Room for Improvement in the Treatment of Helicobacter pylori Infection: Lessons from the European Registry on H. pylori Management (Hp-EuReg)
Journal of Clinical Gastroenterology, Vol. 56, Núm. 2, pp. E98-E108
2021
-
Adverse Event Profile During the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients From the European Registry on H. pylori Management (Hp-EuReg)
The American journal of gastroenterology, Vol. 116, Núm. 6, pp. 1220-1229
-
European registry on helicobacter pylori management: Effectiveness of first and second-line treatment in Spain
Antibiotics, Vol. 10, Núm. 1, pp. 1-15
2020
-
Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp-EuReg)
Helicobacter, Vol. 25, Núm. 5
-
Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg)
Helicobacter, Vol. 25, Núm. 3
2018
-
Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology, Vol. 72, Núm. 20, pp. 2457-2467
2015
-
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments
Alimentary Pharmacology and Therapeutics, Vol. 41, Núm. 8, pp. 768-775